Medicine detail

Ixazomib

Used for: NINLARO ® is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Official label medicine Official label use ID 7803
ixazomib reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.
What It Is Used For

Used for: NINLARO ® is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Active Ingredient

IXAZOMIB CITRATE

Chemical Name

IXAZOMIB CITRATE

Common Brands

NINLARO

Generic / Alternate Names

IXAZOMIB

Tracking Note

Use this entry as a reference/search starting point; verify dose, indication, and safety details with official labeling or a clinician.

Clinical links

Linked conditions and symptoms